AmSurg Senior Vice President of Finance and Chief Accounting Officer Kevin Eastridge took advantage of the 13 percent year-to-date run up in the company's shares to cash in almost a fifth of his shares in the company. Eastridge, who has been with Nashville-based AmSurg since 1997, grossed more than $540,000 on the sale. AmSurg (Ticker: AMSG) is changing hands at a record high and is now worth almost $3 billion.
At behavioral health care provider Acadia Healthcare, VP of Finance Robert Swinson on Monday sold off about 7 percent of his holdings for almost $400,000. Acadia shares (Ticker: ACHC) have climbed about 7 percent year to date.
Two Texas investment firms have declared sizable stakes in local companies. First up, Vaughan Nelson Investment Management of Houston added to its stake in AmSurg late in 2014, finishing the year with more than 2.2 million shares, or 5.9 percent. Vaughan Nelson manages more than $6.6 billion. AmSurg shares (Ticker: AMSG) finished last week at $55.56 and have climbed 11 percent over the past three months.
Further up Interstate 45 in Dallas, Nokomis Capital filed papers to say it now owns almost 1.2 million shares, or 6.8 percent, of home goods retailer Kirkland's. The hedge fund, which was launched in 2008, manages almost $400 million. Kirkland's has been on a good sales and profits run of late, with its shares (Ticker: KIRK) having climbed 35 percent over the past three months.
Analysts at Jeffries Group have begun coverage on Nashville-based AmSurg. Starting last week, the firm gave the ambulatory surgery company a 'buy' rating and a price target of $65. Shares of AmSurg (Ticker: AMSG) closed down about 2 percent at $55.34 Monday. In the last six months, they're up 12 percent.
Andrew Stapp at Hilliard Lyons liked the look of Pinnacle Financial Partners' fourth-quarter numbers. He has hiked his rating on the shares of Nashville's biggest bank to 'buy' from 'long-term buy.' Pinnacle (Ticker: PNFP) ended last week at $37.80 and is up about 5 percent over the past three months.
Over at Piper Jaffray, Kevin Ellich has upgraded AmSurg to 'overweight' from 'neutral,' saying the company now trades at a better valuation. Ellich also raised his target for the Nashville-based company to $65 from $54. AmSurg (Ticker: AMSG) shares finished Friday trading at $55.31 and have climbed about 10 percent over the past three months.
AmSurg executives have signed an agreement to lease more than 200,000 square feet in South Florida, starting in September of next year, for their Sheridan physician services subsidiary. The two-building lease runs through early 2029 and will have the Sheridan home office team move a few miles east from their current spot.
POSTDATA: WARRANTY DEEDS